Literature DB >> 15192176

Myocarditis as a prognostic indicator in systemic lupus erythematosus.

S Busteed1, P Sparrow, C Molloy, M G Molloy.   

Abstract

Lupus myocarditis is a life threatening complication of systemic lupus erythematosus (SLE). A case of left ventricular failure secondary to myocarditis occurring in a patient with SLE is reported. Despite resolution of the cardiac failure with pulsed cyclophosphamide and steroids, she eventually died of non-cardiac complications 18 months later. The literature is also reviewed.

Entities:  

Mesh：

Year:  2004        PMID： 15192176      PMCID： PMC1743021          DOI： 10.1136/pgmj.2003.012450

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  10 in total

1.  Rituximab in childhood lupus myocarditis.

Authors:  Pooja Aggarwal; Surjit Singh; Deepti Suri; Amit Rawat; Nidhi Narula; Rohit ManojKumar
Journal:  Rheumatol Int       Date:  2011-04-06       Impact factor: 2.631

Review 2.  Cardiac Autoimmunity: Myocarditis.

Authors:  William Bracamonte-Baran; Daniela Čiháková
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  SLE with recurrent heart failure and a dermatological clue to another added possibility.

Authors:  Luciano Candilio; David D'Cruz; Divaka Perera
Journal:  BMJ Case Rep       Date:  2011-04-15

4.  Case of severe acute lupus myocarditis and multiple-organ failure.

Authors:  Aaron M Hawkins; Lalith S B Jesuthasan; Deepak L Vardesh
Journal:  BMJ Case Rep       Date:  2018-06-19

Review 5.  [Inflammatory cardiac diseases by primary extracardial diseases].

Authors:  M Brehm; P Rellecke; B E Strauer
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

6.  Aggressive cardiac involvement in systemic lupus erythematosus: a case report and a comprehensive literature review.

Authors:  Reza Ashrafi; Pankaj Garg; Ewan McKay; John Gosney; Som Chuah; Gershan Davis
Journal:  Cardiol Res Pract       Date:  2011-02-15       Impact factor: 1.866

7.  Systemic autoimmunity induced by the TLR7/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart disease.

Authors:  Muneer G Hasham; Nicoleta Baxan; Daniel J Stuckey; Jane Branca; Bryant Perkins; Oliver Dent; Ted Duffy; Tolani S Hameed; Sarah E Stella; Mohammed Bellahcene; Michael D Schneider; Sian E Harding; Nadia Rosenthal; Susanne Sattler
Journal:  Dis Model Mech       Date:  2017-03-01       Impact factor: 5.758

8.  Myocarditis with Cardiogenic Shock as the First Manifestation of Systemic Lupus Erythematosus.

Authors:  Jáder Buzati Rebelato; Caroline Ferreira da Silva Mazeto Pupo da Silveira; Tainá Fabri Carneiro Valadão; Fabrício Moreira Reis; Rodrigo Bazan; Silméia Garcia Zanati Bazan
Journal:  Arq Bras Cardiol       Date:  2018-12       Impact factor: 2.000

Review 9.  Epidemiological Impact of Myocarditis.

Authors:  Ainoosh Golpour; Dimitri Patriki; Paul J Hanson; Bruce McManus; Bettina Heidecker
Journal:  J Clin Med       Date:  2021-02-05       Impact factor: 4.241

10.  Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention-A Report from the 2021 National Heart, Lung, and Blood Institute Workshop.

Authors:  Daniela Čiháková; Yang Shi; Bishow Adhikari; W Patricia Bandettini; Madeleine W Cunningham; Narasimhan Danthi; Matthias G Friedrich; Peter Liu; Lisa Schwartz Longacre; Douglas L Mann; Filip K Swirski; W H Wilson Tang; Guofei Zhou; Leslie T Cooper
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.